Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Jakko van Ingen¹, Stefano Aliberti^{2

3}, Claire Andrejak⁴, James D Chalmers⁵, Luigi R Codecasa⁶, Charles L Daley⁷, Naoki Hasegawa⁸, David E Griffith⁹, Wouter Hoefsloot¹⁰, Gwen Huitt⁷, Julie Jarand¹¹, Byung Woo Jhun¹², Michael R Loebinger^{13

14}, Theodore K Marras¹⁵, Kozo Morimoto¹⁶, Eva Polverino¹⁷, Felix C Ringshausen¹⁸, Miguel Santin¹⁹, Rachel Thomson²⁰, Dirk Wagner²¹, Richard J Wallace²², Kevin L Winthrop²³, Jae-Joon Yim²⁴

Affiliations

¹ Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
² University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy.
³ Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy.
⁴ Department of Pneumology, University Hospital of Amiens-Picardie, Amiens, France.
⁵ Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
⁶ Regional Tuberculosis Reference Centre, Villa Marelli Institute-Niguarda Hospital, Milan, Italy.
⁷ Division of Mycobacterial and Respiratory Infections, National Jewish Health and University of Colorado, Denver, Colorado, USA.
⁸ Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
⁹ Department of Medicine, University of Texas Health Science Center at Tyler, Tyler, Texas, USA.
¹⁰ Center for Infectious Diseases, Department of Pulmonology, Radboud University Medical Center, Nijmegen, The Netherlands.
¹¹ Division of Respiratory Medicine, Department of Medicine, University of Calgary, Calgary, Canada.
¹² Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
¹³ Host Defence Unit, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
¹⁴ National Heart and Lung Institute, Imperial College, London, United Kingdom.
¹⁵ Departments of Medicine at the Toronto Western Hospital/University Health Network and the University of Toronto, Toronto, Canada.
¹⁶ Respiratory Disease Center, Fukujuji Hospital, Anti-Tuberculosis Association, Tokyo, Japan.
¹⁷ Servei de Pneumologia, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, Spain.
¹⁸ Department of Respiratory Medicine, Hannover Medical School and Biomedical Research in Endstage and Obstructive Lung Disease Hannover, German Center for Lung Research, Hannover, Germany.
¹⁹ Service of Infectious Diseases, Bellvitge University Hospital, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
²⁰ Gallipoli Medical Research Institute, University of Queensland, Brisbane, Australia.
²¹ Division of Infectious Diseases, Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
²² Mycobacteria/Nocardia Research Laboratory, University of Texas Health Science Center at Tyler, Tyler, Texas, USA.
²³ Oregon Health and Science University, Portland, Oregon, USA.
²⁴ Division of Pulmonary and Critical Care Medicine, Seoul National University College of Medicine, Seoul, South Korea.

PMID: 32910814
PMCID: PMC8491833
DOI: 10.1093/cid/ciaa1361

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Jakko van Ingen et al. Clin Infect Dis. 2021.

. 2021 Jul 1;73(1):e256-e259.

doi: 10.1093/cid/ciaa1361.

Authors

Affiliations

¹ Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
² University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy.
³ Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy.
⁴ Department of Pneumology, University Hospital of Amiens-Picardie, Amiens, France.
⁵ Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
⁶ Regional Tuberculosis Reference Centre, Villa Marelli Institute-Niguarda Hospital, Milan, Italy.
⁷ Division of Mycobacterial and Respiratory Infections, National Jewish Health and University of Colorado, Denver, Colorado, USA.
⁸ Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
⁹ Department of Medicine, University of Texas Health Science Center at Tyler, Tyler, Texas, USA.
¹⁰ Center for Infectious Diseases, Department of Pulmonology, Radboud University Medical Center, Nijmegen, The Netherlands.
¹¹ Division of Respiratory Medicine, Department of Medicine, University of Calgary, Calgary, Canada.
¹² Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
¹³ Host Defence Unit, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
¹⁴ National Heart and Lung Institute, Imperial College, London, United Kingdom.
¹⁵ Departments of Medicine at the Toronto Western Hospital/University Health Network and the University of Toronto, Toronto, Canada.
¹⁶ Respiratory Disease Center, Fukujuji Hospital, Anti-Tuberculosis Association, Tokyo, Japan.
¹⁷ Servei de Pneumologia, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, Spain.
¹⁸ Department of Respiratory Medicine, Hannover Medical School and Biomedical Research in Endstage and Obstructive Lung Disease Hannover, German Center for Lung Research, Hannover, Germany.
¹⁹ Service of Infectious Diseases, Bellvitge University Hospital, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
²⁰ Gallipoli Medical Research Institute, University of Queensland, Brisbane, Australia.
²¹ Division of Infectious Diseases, Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
²² Mycobacteria/Nocardia Research Laboratory, University of Texas Health Science Center at Tyler, Tyler, Texas, USA.
²³ Oregon Health and Science University, Portland, Oregon, USA.
²⁴ Division of Pulmonary and Critical Care Medicine, Seoul National University College of Medicine, Seoul, South Korea.

PMID: 32910814
PMCID: PMC8491833
DOI: 10.1093/cid/ciaa1361

Abstract

Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.

Keywords: Mycobacterium avium complex; adverse events; antibiotic treatment; azithromycin; nontuberculous mycobacteria.

PubMed Disclaimer

References

1. Diel R, Nienhaus A, Ringshausen FC, et al. . Microbiologic outcome of interventions against Mycobacterium avium complex pulmonary disease: a systematic review. Chest 2018; 153:888–921. - PubMed
1. Wallace RJ Jr, Brown-Elliott BA, McNulty S, et al. . Macrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest 2014; 146:276–82. - PMC - PubMed
1. Jeong BH, Jeon K, Park HY, et al. . Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2015; 191:96–103. - PubMed
1. Zweijpfenning S, Kops S, Magis-Escurra C, Boeree MJ, van Ingen J, Hoefsloot W. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort. Respir Med 2017; 131:220–4. - PubMed
1. Morimoto K, Namkoong H, Hasegawa N, et al. , Nontuberculous Mycobacteriosis Japan Research Consortium . Macrolide-resistant Mycobacterium avium complex lung disease: analysis of 102 consecutive cases. Ann Am Thorac Soc 2016; 13:1904–11. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Affiliations

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Authors

Affiliations

Abstract

References

MeSH terms

LinkOut - more resources

Full Text Sources

Medical